axtle
Generic: pemetrexed
Labeler: avyxa pharma, llcDrug Facts
Product Profile
Brand Name
axtle
Generic Name
pemetrexed
Labeler
avyxa pharma, llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
pemetrexed 500 mg/20mL
Manufacturer
Identifiers & Regulatory
Product NDC
83831-132
Product ID
83831-132_6e125601-ebbb-4fe6-9d9e-80d093b12532
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA210661
Listing Expiration
2026-12-31
Marketing Start
2025-01-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
83831132
Hyphenated Format
83831-132
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
axtle (source: ndc)
Generic Name
pemetrexed (source: ndc)
Application Number
NDA210661 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/20mL
Packaging
- 1 VIAL in 1 CARTON (83831-132-01) / 20 mL in 1 VIAL
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "6e125601-ebbb-4fe6-9d9e-80d093b12532", "openfda": {"nui": ["N0000175584", "N0000000111"], "upc": ["0383831131014", "0383831132011"], "unii": ["04Q9AIZ7NO"], "rxcui": ["1728072", "1728077", "2699339", "2699341"], "spl_set_id": ["9582c46c-d8b0-44b7-a2ee-9c86f5e9b7b1"], "pharm_class_epc": ["Folate Analog Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Folic Acid Metabolism Inhibitors [MoA]"], "manufacturer_name": ["Avyxa Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (83831-132-01) / 20 mL in 1 VIAL", "package_ndc": "83831-132-01", "marketing_start_date": "20250101"}], "brand_name": "AXTLE", "product_id": "83831-132_6e125601-ebbb-4fe6-9d9e-80d093b12532", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "83831-132", "generic_name": "pemetrexed", "labeler_name": "Avyxa Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AXTLE", "active_ingredients": [{"name": "PEMETREXED", "strength": "500 mg/20mL"}], "application_number": "NDA210661", "marketing_category": "NDA", "marketing_start_date": "20250101", "listing_expiration_date": "20261231"}